Free Trial
NASDAQ:AIFF

Firefly Neuroscience 4/3/2025 Earnings Report

Firefly Neuroscience logo
$3.30 +0.10 (+3.13%)
Closing price 04:00 PM Eastern
Extended Trading
$3.25 -0.05 (-1.52%)
As of 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Firefly Neuroscience EPS Results

Actual EPS
-$0.45
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Firefly Neuroscience Revenue Results

Actual Revenue
$0.05 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Firefly Neuroscience Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Firefly Neuroscience's next earnings date is estimated for Tuesday, May 13, 2025, based on past reporting schedules.

Conference Call Resources

Firefly Neuroscience Earnings Headlines

Financial Survey: Firefly Neuroscience (AIFF) versus Its Peers
Trump Treasure April 19
Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…
Firefly Neuroscience appoints new chairman
See More Firefly Neuroscience Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Firefly Neuroscience? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Firefly Neuroscience and other key companies, straight to your email.

About Firefly Neuroscience

Firefly Neuroscience (NASDAQ:AIFF), a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.

View Firefly Neuroscience Profile

More Earnings Resources from MarketBeat